Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce D Walker

Showing results (271-280 of 490) with videos related to

Pageof 49
Sort By:
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Point-of-care testing for COVID-19 using SHERLOCK diagnosticsJulia Joung, Alim Ladha, Makoto Saito, et al.
The Journal of Experimental Medicine|September 24, 2004
Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cellsMathias Lichterfeld, Daniel E Kaufmann, Xu G Yu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2006
Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infectionSigall Kassutto, Kaveh Maghsoudi, Mary N Johnston, et al.
Blood|October 27, 2005
Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted NefDaniel G Kavanagh, Daniel E Kaufmann, Sherzana Sunderji, et al.
Mbio|November 16, 2021
HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral TherapyF Harrison Omondi, Hanwei Sudderuddin, Aniqa Shahid, et al.
The Journal of Clinical Investigation|September 17, 2003
Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramersCheryl L Day, Nilufer P Seth, Michaela Lucas, et al.
The Journal of Infectious Diseases|February 16, 2008
Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapyFlorencia Pereyra, Marylyn M Addo, Daniel E Kaufmann, et al.
Nature Medicine|January 14, 2014
HIV-1 persistence in CD4+ T cells with stem cell-like propertiesMaria J Buzon, Hong Sun, Chun Li, et al.
The Lancet. Infectious Diseases|January 3, 2016
Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort studyElizabeth H Byrne, Melis N Anahtar, Kathleen E Cohen, et al.
Plos One|September 3, 2011
A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected ThaisSupranee Buranapraditkun, Ursula Hempel, Patrawadee Pitakpolrat, et al.
Pageof 49

Showing results (271-280 of 490) with videos related to

Sort By:
Pageof 49
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Point-of-care testing for COVID-19 using SHERLOCK diagnosticsJulia Joung, Alim Ladha, Makoto Saito, et al.
The Journal of Experimental Medicine|September 24, 2004
Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cellsMathias Lichterfeld, Daniel E Kaufmann, Xu G Yu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2006
Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infectionSigall Kassutto, Kaveh Maghsoudi, Mary N Johnston, et al.
Blood|October 27, 2005
Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted NefDaniel G Kavanagh, Daniel E Kaufmann, Sherzana Sunderji, et al.
Mbio|November 16, 2021
HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral TherapyF Harrison Omondi, Hanwei Sudderuddin, Aniqa Shahid, et al.
The Journal of Clinical Investigation|September 17, 2003
Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramersCheryl L Day, Nilufer P Seth, Michaela Lucas, et al.
The Journal of Infectious Diseases|February 16, 2008
Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapyFlorencia Pereyra, Marylyn M Addo, Daniel E Kaufmann, et al.
Nature Medicine|January 14, 2014
HIV-1 persistence in CD4+ T cells with stem cell-like propertiesMaria J Buzon, Hong Sun, Chun Li, et al.
The Lancet. Infectious Diseases|January 3, 2016
Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort studyElizabeth H Byrne, Melis N Anahtar, Kathleen E Cohen, et al.
Plos One|September 3, 2011
A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected ThaisSupranee Buranapraditkun, Ursula Hempel, Patrawadee Pitakpolrat, et al.
Pageof 49